
CTNM
Contineum Therapeutics Inc.
$11.27
-$1.23(-9.84%)
66
Overall
--
Value
66
Tech
--
Quality
Market Cap
$333.00M
Volume
156.04K
52W Range
$3.35 - $20.24
Target Price
$22.80
Order:
Income Statement
Metric | Trend | Chart | 2024 Dec |
---|---|---|---|
OPERATING EXPENSES | |||
Operating Expenses | $50.9M | ||
Research & Development | $38.4M | ||
Research Expense | $38.4M | ||
Selling, General & Administrative | $12.5M | ||
General & Administrative Expenses | $12.5M | ||
Salaries & Wages | $200.0K | ||
Depreciation & Amortization | $258.0K | ||
Depreciation & Amortization | $258.0K | ||
Other Operating Expenses | $-525.0K | ||
OPERATING INCOME | |||
Operating income | $-50.9M | ||
EBITDA | $-41.1M | ||
NON-OPERATING ITEMS | |||
Intinc | $8.9M | ||
Net Non-Operating Interest Income/Expense | $8.9M | ||
Other Income/Expense | $269.0K | ||
Other Special Charges | $-269.0K | ||
PRE-TAX INCOME | |||
EBIT | $-42.3M | ||
Pre-Tax Income | $-42.3M | ||
NET INCOME | |||
Net Income | $-42.3M | ||
Net Income (Continuing Operations) | $-42.3M | ||
Net Income (Discontinued Operations) | $-42.3M | ||
Net Income (Common Stockholders) | $-42.3M | ||
Normalized Income | $-41.8M | ||
TOTALS | |||
Total Expenses | $50.9M | ||
SHARE & EPS DATA | |||
Average Shares Outstanding | $19.4M | ||
Average Shares Outstanding (Diluted) | $19.4M | ||
Shares Outstanding | $25.9M | ||
Basic EPS | $-2.18 | ||
Basic EPS (Continuing Operations) | $-2.18 | ||
Diluted EPS | $-2.18 | ||
Diluted EPS (Continuing Operations) | $-2.18 | ||
OTHER METRICS | |||
Accrued Preferred Stock Dividends | $42.3M | ||
Other Gand A | $12.5M | ||
Otherunder Preferred Stock Dividend | $42.3M | ||
Preferred Stock Dividends | $42.3M |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | CTNM | $11.27 | -9.8% | 156.04K |
3 | ||||
4 | ||||
5 | ||||
6 |
Get Contineum Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW